Periostin as a predictor of prognosis in chronic bird-related hypersensitivity pneumonitis.


Journal

Allergology international : official journal of the Japanese Society of Allergology
ISSN: 1440-1592
Titre abrégé: Allergol Int
Pays: England
ID NLM: 9616296

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 21 10 2018
revised: 25 01 2019
accepted: 12 02 2019
pubmed: 16 3 2019
medline: 21 12 2019
entrez: 16 3 2019
Statut: ppublish

Résumé

Periostin is an established biomarker of Th2 immune response and fibrogenesis. Recent research has indicated that periostin plays an important role in the pathogenesis of idiopathic interstitial pneumonias. To clarify the relationship between periostin and pathogenesis in chronic bird-related hypersensitivity pneumonitis (HP) and to reveal the usefulness of serum periostin levels in diagnosing and managing chronic bird-related HP. We measured serum periostin in 63 patients with chronic bird-related HP, 13 patients with idiopathic pulmonary fibrosis, and 113 healthy volunteers. We investigated the relationship between serum periostin and clinical parameters, and evaluated if the baseline serum periostin could predict the prognosis. Serum periostin was significantly higher in patients with chronic bird-related HP compared to the healthy volunteers. In chronic bird-related HP, serum periostin had significant positive correlations with serum KL-6 levels, the CD4/CD8 ratio in bronchoalveolar lavage fluid, and fibrosis score on HRCT, and a significant negative correlation with the diffusing capacity of the lungs for carbon monoxide. Chronic bird-related HP patients with serum periostin levels exceeding ≥92.5 ng/mL and ≥89.5 ng/mL had a significantly worse prognosis and significantly higher frequency of acute exacerbation, respectively. Higher serum periostin (92.5 ng/mL or higher; binary response for serum periostin) was an independent prognostic factor in multivariate analysis. Serum periostin may reflect the extent of lung fibrosis and play an important role in pathogenesis of chronic bird-related HP. Elevated serum periostin could be a predictor of prognosis in patients with chronic bird-related HP.

Sections du résumé

BACKGROUND BACKGROUND
Periostin is an established biomarker of Th2 immune response and fibrogenesis. Recent research has indicated that periostin plays an important role in the pathogenesis of idiopathic interstitial pneumonias. To clarify the relationship between periostin and pathogenesis in chronic bird-related hypersensitivity pneumonitis (HP) and to reveal the usefulness of serum periostin levels in diagnosing and managing chronic bird-related HP.
METHODS METHODS
We measured serum periostin in 63 patients with chronic bird-related HP, 13 patients with idiopathic pulmonary fibrosis, and 113 healthy volunteers. We investigated the relationship between serum periostin and clinical parameters, and evaluated if the baseline serum periostin could predict the prognosis.
RESULTS RESULTS
Serum periostin was significantly higher in patients with chronic bird-related HP compared to the healthy volunteers. In chronic bird-related HP, serum periostin had significant positive correlations with serum KL-6 levels, the CD4/CD8 ratio in bronchoalveolar lavage fluid, and fibrosis score on HRCT, and a significant negative correlation with the diffusing capacity of the lungs for carbon monoxide. Chronic bird-related HP patients with serum periostin levels exceeding ≥92.5 ng/mL and ≥89.5 ng/mL had a significantly worse prognosis and significantly higher frequency of acute exacerbation, respectively. Higher serum periostin (92.5 ng/mL or higher; binary response for serum periostin) was an independent prognostic factor in multivariate analysis.
CONCLUSIONS CONCLUSIONS
Serum periostin may reflect the extent of lung fibrosis and play an important role in pathogenesis of chronic bird-related HP. Elevated serum periostin could be a predictor of prognosis in patients with chronic bird-related HP.

Identifiants

pubmed: 30871804
pii: S1323-8930(19)30020-6
doi: 10.1016/j.alit.2019.02.007
pii:
doi:

Substances chimiques

Biomarkers 0
Cell Adhesion Molecules 0
MUC1 protein, human 0
Mucin-1 0
POSTN protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

363-369

Informations de copyright

Copyright © 2019 Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.

Auteurs

Yoshihisa Nukui (Y)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Yasunari Miyazaki (Y)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan. Electronic address: miyazaki.pilm@tmd.ac.jp.

Masahiro Masuo (M)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Tsukasa Okamoto (T)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Haruhiko Furusawa (H)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Tomoya Tateishi (T)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Mitsuhiro Kishino (M)

Department of Diagnostic Radiology, Tokyo Medical and Dental University, Tokyo, Japan.

Ukihide Tateishi (U)

Department of Diagnostic Radiology, Tokyo Medical and Dental University, Tokyo, Japan.

Junya Ono (J)

Shino-Test Corporation, Sagamihara, Japan.

Shoichiro Ohta (S)

Department of Medical Technology and Sciences, School of Health Sciences at Fukuoka, International University of Health and Welfare, Fukuoka, Japan.

Kenji Izuhara (K)

Division of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, Saga, Japan.

Naohiko Inase (N)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH